Results

Total Results: 1,187 records

Showing results for "weeks".

341. Appendicitis Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/appendicitis_executive.pdf
     December 01, 2015 - appendectomy in the first trimester, developed severe preeclampsia and had a premature delivery at 33 weeks … appendectomy in the first trimester, developed severe preeclampsia and had a premature delivery at 33 weeks … after CT-diagnosed gastric cancer, two had spontaneous vaginal delivery of a nonviable fetus (1 at 18 weeks … with sepsis after normal CT and normal laparotomy, and 1 at 22 weeks with chorioamnionitis, 5 days … There was one fetal death at 26 weeks (4 weeks after a CT examination with normal findings).

342. Untitled (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/heart-disease-ace-inhibitor-arb_surveillance.pdf
     July 06, 2015 - LCZ696 titrated to 200 mg twice daily or valsartan titrated to 160 mg twice daily, and treated for 36 weeks … NT-proBNP was significantly reduced at 12 weeks in the LCZ696 group compared with the valsartan group … (LCZ696: baseline, 783 pg/mL [95% CI 670-914], 12 weeks, 605 pg/mL [512-714]; valsartan: baseline, 862 … pg/mL [733-1012], 12 weeks, 835 [710-981]; ratio LCZ696/valsartan, 077, 95% CI 064-092, p=0005). … preserved ejection fraction, LCZ696 reduced NT-proBNP to a greater extent than did valsartan at 12 weeks

343. Diabetes-Behavior-Programs Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-behavior-programs_research-protocol.pdf
     June 05, 2014 - diabetes-specific program with repeated interactions by one or more trained individuals, with a duration of ≥4 weeks … • Repeated provision by one or more trained individuals • Duration of intervention: minimum 4 weeks … • Repeated provision by one or more trained individuals • Duration of intervention: minimum 4 weeks … Duration of ≥4 weeks. … The minimum duration of 4 weeks does not include post-intervention follow-up assessments for outcome

344. Ptsd-Adult-Treatment Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_executive.pdf
     April 01, 2013 - the symptoms of PTSD; in most people, those symptoms resolve spontaneously in the first several weeks … We included randomized controlled trials (RCTs) of at least 4 weeks in duration for KQs 1 through 5 … those, just one compared medications that have evidence supporting their efficacy: it compared 12 weeks … Study durations ranged from 8 to 24 weeks and were generally not designed to assess adverse events. … true for the pharmacological treatments because trials generally reported outcomes after 8 to 12 weeks

345. Facilitating the Implementation of EPC Reports_Methods Research Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-report-facilitating-implementation-pilot.pdf
     October 01, 2019 - clinician also mentioned that similar education trainings at Mayo Clinic are provided in blocks of four weeks … so that parents are not committed to 12 consecutive weeks of the program.

346. The Effect of Dietary Digestible Carbohydrate Intake on Risk of Cardiovascular Disease (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/risk-cardiovascular-disease.pdf
     January 01, 2023 - preeclampsia- eclampsia, chronic hypertension with superimposed preeclampsia) Timing • At least 4 weeks … • Less than 4 weeks Settings • All except hospital and acute care • Hospital and acute care 4

347. Hypertension-Pulmonary-Arterial Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hypertension-pulmonary-arterial_research-protocol.pdf
     January 30, 2013 - Published online: January 30, 2013 5 • Changing the intermediate timeframe to 120 days, 4 months, or 16 weeks … site pain, abrupt catheter occlusion) • Timing: o Intermediate-term (≤120 days, 4 months, 16 weeks … are the usual time points for the efficacy studies) o Long-term (>120 days, 4 months, 16 weeks) … aFor all included studies, we will indicate the total number of patients enrolled and longest length (weeks

348. High-Cholestorol-Medicines-Update Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
     February 01, 2014 - Included randomized controlled trials Included nonrandomized extension of clinical trial over 24 weeks … Excluded crossover trials with fewer than 4 weeks washout and/or lacking paired observation, within-person … LDL < 160 mg/dl) = 4 Not an RCT or non-randomized that is extension of RCT that lasts > 24 weeks … or meeting abstract) = 12 Not an RCT or non-randomized that is extension of RCT that lasts >24 weeks

349. Systematic Review Update: Noninvasive Nonpharmacologic Treatment for Chronic Pain (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/nonpharm-treatment-chronic-pain-protocol.pdf
     December 11, 2018 - including pregnant or breastfeeding women) with the following chronic pain (defined as pain lasting 12 weeks … treatment for chronic pain KQ=Key Question aChronic pain is defined as pain lasting ≥ 12 weeks … General Inclusion Criteria • Adults with the following chronic pain (defined as pain lasting 12 weeks … o Chronic headache is defined as 15 or more days each month for at least 12 weeks or history of headache

350. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/antipsychotics-children-update-disposition-170621.pdf
     March 16, 2017 - Because the length of studies 3 weeks to months is so different, it may help the reader put some context … “Adequate trials of antipsychotic treatment to assess response can be considered within 4 to 6 weeks … generally safe and well tolerated in pediatric subjects with bipolar disorder treated for up to 52 weeks

351. First- and Second-Generation Antipsychotics in Children and Young Adults: Systematic Review Update (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antipsychotics-children-update-disposition-170621.pdf
     March 16, 2017 - Because the length of studies 3 weeks to months is so different, it may help the reader put some context … “Adequate trials of antipsychotic treatment to assess response can be considered within 4 to 6 weeks … generally safe and well tolerated in pediatric subjects with bipolar disorder treated for up to 52 weeks

352. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/juvenile-arthritis-dmards_executive.pdf
     September 01, 2011 - • Undifferentiated: Arthritis lasting more than 6 weeks that does not meet the criteria for any of … arthritis • Psoriatic arthritis • Other (arthritis of unknown cause with symptoms lasting more than 6 weeks

353. Evidence Summary: Comparative Effectiveness Review No. 236 Maternal, Fetal, and Child Outcomes of Mental Health Treatments in Women: A Systematic Review of Perinatal Pharmacologic Interventions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-236-mental-health-pregnancy-evidence-summary.pdf
     April 01, 2021 - For depression onset in the third trimester or within 4 weeks of birth, brexanolone may be associated

354. Evidence Summary_Comparative Effectiveness Review No. 248: Prehabilitation and Rehabilitation for Major Joint Replacement (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/joint-replacement-evidence%20-summary.pdf
     November 01, 2021 - intensive active rehabilitation), rehabilitation in the acute phase after TKA (initiated within 2 weeks

355. Obesity (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/obesity-horizon-scan-high-impact-1506.pdf
     June 01, 2015 - diet and exercise (DUO, n=187) or sham endoscopy plus diet and exercise alone (DIET, n=139) for 24 weeks … The DUO group was reported to have achieved significantly greater %EWL at 24 weeks (25.1% intent-to-treat … had 8% mean weight loss compared with 2.6% mean weight loss in the placebo group (n=1,220) after 56 weeks … Safety and tolerability of liraglutide 3.0mg following 56 weeks of randomised treatment in overweight

356. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - of repeat rifaximin therapy in 636 patients who had recurrent diarrhea-predominant IBS within 18 weeks … The primary endpoint was the proportion of treatment responders during at least 2 of the 4 weeks of … however, the remainder (64% [692 of 1,074]) of initial responders had relapsed disease at up to 18 weeks

357. Management of Postpartum Hemorrhage: Current State of the Evidence (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/hemorrhage-postpartum_clinician.pdf
     July 01, 2016 - hours of birth) or secondary/delayed/late (occurring from more than 24 hours postbirth to up to 12 weeks

358. Executive Summary_Systematic Review: Mental Health and Occupational Stress in the Emergency Medical Services and 911 Workforces (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-mental-health-executive-summary.pdf
     February 01, 2025 - Executive Summary_Systematic Review: Mental Health and Occupational Stress in the Emergency Medical Services and 911 Workforces Systematic Review M ental Health and Occupational Stress in the Emergency Medical Services and 911 Workforces Executive Summary Main Points • No study reported o…

359. Restless-Legs Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/restless-legs_research-protocol.pdf
     December 16, 2011 - Timing  Minimum of 4 weeks. …  Study duration is at least 4 weeks. …  Studies that evaluate only acute effects (< 4 weeks) of treatment.

360. Insomnia_protocol-140403 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/insomnia_protocol-140716.pdf
     April 03, 2014 - minimum timeframe for sleep difficulties; chronic insomnia was used to describe cases that lasted from weeks … Timing KQ1: Outcomes measured at 4 weeks to 3 months after initiation of treatment will be used to … with diagnoses consistent with insomnia disorder: enrollment o efficacy/comparative effectiveness: 4 weeks